Recombinant Rat IL-13

Leinco Technologies
Product Code: LEI-I-220
Product Group: Recombinant Proteins
CodeSizePrice
LEI-I-220-25ug25 ug£580.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rat
Regulatory Status: RUO
Shipping:
Ambient
Storage:
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.

Further Information

Format:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Formulation:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Long Description:
Interleukin 13 (IL-13), also known as ALRH, is a single-chain, glycosylated polypeptide and a cytokine that is critical in regulating inflammatory and immune responses.1 It is produced primarily by activated Th2 cells, as well as mast cells and NK cells.1 The functions of IL-13 overlap considerably with those of IL-4 but these effects are probably less important given the more potent role of IL-4.2 IL-13 exerts its effects through a multi-subunit receptor comprising the alpha chain of the IL-4 receptor (IL-4Rα), and at least one of two known IL-13-specific binding chains (IL13 Rα1 and IL13 Rα2). Most of the biological effects of IL-13, like those of IL-4, are linked to signal transducer and activator of transcription 6 (STAT6).2 Although IL-13 is associated primarily with the induction of airway disease, it also has anti-inflammatory properties. It exerts these anti-inflammatory effects on monocytes and macrophages, and inhibits the expression of inflammatory cytokines such as IL-1beta, TNF-alpha, IL-6 and IL-8. IL-13 has also been shown to enhance B cell proliferation and to induce isotype switching resulting in increased production of IgE.3 Blocking of IL-13 activity inhibits the pathophysiology of asthma.4 Targeted deletion of IL-13 in mice results in impaired Th2 cell development and indicates an important role for IL-13 in the expulsion of gastrointestinal parasites.5 In addition, studies have identified IL-13 expression as a common feature of cHL (classical Hodgkin lymphoma).6 Human and murine IL-13 is cross-species reactive.
NCBI Gene:
116553
Purity:
>97% by SDS-PAGE and analyzed by silver stain.
Target:
IL-13

References

1. Wynn, TA. et al. (2003) Annu Rev Immunol. 21: 425 2. Citrin, DE. et al. (2016) Sci Rep. 6:39714.

Related Products

Product NameProduct CodeSupplier 
Anti-Human IL-13LEI-I-156Leinco Technologies Summary Details
Recombinant Human IL-13LEI-I-195Leinco Technologies Summary Details
Anti-Human IL-13 - BiotinLEI-I-269Leinco Technologies Summary Details
Recombinant Mouse IL-13LEI-I-278Leinco Technologies Summary Details
Anti-Mouse IL-13LEI-I-348Leinco Technologies Summary Details
Anti-Mouse IL-13 - BiotinLEI-I-349Leinco Technologies Summary Details
Anti-Human IL-13 (Clone 32116)LEI-I-634Leinco Technologies Summary Details
Anti-Mouse IL-13 (Clone 38213)LEI-I-665Leinco Technologies Summary Details
Anti-Rat IL-13LEI-I-854Leinco Technologies Summary Details
Anti-Rat IL-13 - BiotinLEI-I-864Leinco Technologies Summary Details
Anti-Rat IL-13 (Clone 296202)LEI-I-874Leinco Technologies Summary Details